Pressrelease 5 June 2006
A Significant Preclinical Milestone Achieved
A significant preclinical milestone has been achieved today. GLX010 shows hypoglycemic effect in experiments carried out in an animal model of insulin resistance. GLX010 treatment considerably reduced blood glucose levels and prevented elevation of hyperglycemia. These novel results strongly indicate a new therapeutic candidate for treatment of type 2 diabetic patients.
Download a pdf of the Pressrelease
Pressrelease 15 May 2007
Promising Results in Treatment with GLX
Pressrelease 29 December 2006
US Patent Received for Diabetes Treatment
Pressrelease 28 September 2006
Glucox' Unique Research Discovery Confirmed by US Scientist
Pressrelease 10 July 2006
Patent Application Submitted for the GLX Compounds
Pressrelease 5 June 2006
A Significant Preclinical Milestone Achieved
Pressrelease 7 February 2006
Positive Results from the First Time In Animal Study
Pressrelease 10 January 2006
Pressrelease 10 November 2005
Evaluation and Selection of Glucox Biotech' Lead Drug Candidates